Skip to main content
ConductScienceScienceDex

Todd W Vanderah

NIH Rank #9944
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1875034Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Physiology

NIH Funding · FY2026

Linked Award Amount
$964.8K
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#9,944
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Todd W Vanderah. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Todd W Vanderah as a PI. Multi-PI records show the full award amount for context.

  • 5R01DA056608-03R01
    Endocannabinoid Targeting for Opioid Induced Respiratory Depression
    University of Arizona
    $536.9K
    award amount
  • 2T32GM141830-06T32
    Interdisciplinary Training of Future Physician Scientists
    University of Arizona
    $293.8K
    award amount
  • 3U01AG082617-03S1U01
    PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
    University of Arizona
    $134.1K
    award amount

Award organization

Organizations that administered FY2026 awards listing Todd W Vanderah as a PI.

FY2026 award administered by University of Arizona (AZ).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Arizona
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5214
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #3074
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Todd W Vanderah.

Tally Marie Milnes
University of Arizona
4
shared awards
Jason A Wertheim
University of Arizona
3
shared awards
Juanita L. Merchant
University of Arizona
3
shared awards
Meredith Hay
University of Arizona
3
shared awards
Edita Navratilova
University of Arizona
2
shared awards
Frank Porreca
University of Arizona
2
shared awards
Michael L Heien
University of Arizona
2
shared awards
Stephen Leigh Cowen
University of Arizona
2
shared awards
Bridget S Murphy
University of Arizona
1
shared award
Christopher J Edwards
University of Arizona
1
shared award

Explore further

Find collaborators for Todd W Vanderah

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →